Orthofix International | OFIX - 销售成本

金融业

USD

USD 886.6M

现金及等价物

USD 120.28M

USD 66.63M

USD 461.52M

USD 161.03M

USD 137.24M

股息收益率

0

USD 6.12M

USD 27.88M

1.09K

EPS每股收益

USD 0.09

股本和储备

USD 435.19M

USD 153.28M

债务利息支出

4.68M

USD 221.34M

USD 389.4M

USD -2.22M

USD 213.79M

USD 6.12M

普通股股本

USD 39.83M

4.17K

USD -2.19M

USD 219.91M

销售和管理费用

USD 130.35M

USD 177.82M

贸易债权人

USD 54.69M

应收帐款人

USD 135.75M

	销售成本	更改		日
Accuray	USD 116.17M		14.63M	2024-12
AngioDynamics	USD 37.29M		786K	2025-09
Artivion	USD 42.85M		3.86M	2025-12
AtriCure	USD 31.94M		3.22M	2026-03
Dexcom	USD 441.6M		25.3M	2026-03
EDAP TMS	EUR 7.91M		1.31M	2025-09
Globus Medical	USD 263.59M		26.88M	2026-03
Inogen	USD 39.59M		1.27M	2024-09
Insulet	USD 232.7M		17.5M	2026-03
Integra LifeSciences	USD 178.71M		14.73M	2026-03
J&J	USD 8.07B		103M	2026-03
Medtronic	USD 3.61B		83M	2025-12
Mesa Laboratories	USD 21.92M		1.78M	2024-09
Orthofix International	USD 66.63M		6.4M	2025-12
Smith & Nephew	USD 870M		17M	2025-12
STAAR Surgical	USD 24.66M		10.6M	2026-03
Stryker	USD 2.36B		325M	2026-03
Surmodics	USD 9.49M		23.54M	2025-06
Tandem Diabetes Care	USD 122.92M		7.96M	2025-12
Teleflex	USD 240.84M		20.7M	2026-03
Veracyte	USD 38.49M		794K	2026-03
Zimmer Biomet Holdings	USD 738.3M		231.8M	2026-03